Cathleen McCabe MD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed ·

Quick facts

Marketed products

Durezol 0.05% Ophthalmic Emulsion · Ophthalmology
Durezol (difluprednate) is a topical corticosteroid that suppresses inflammatory responses in the eye by inhibiting phospholipase A2 and reducing production of inflammatory mediators.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Cathleen McCabe MD portfolio CI brief
Cathleen McCabe MD pipeline updates RSS

Frequently asked questions about Cathleen McCabe MD

What are Cathleen McCabe MD's marketed drugs?

Top marketed products include Durezol 0.05% Ophthalmic Emulsion.

Durezol 0.05% Ophthalmic Emulsion · Ophthalmology
Sector hub: All tracked pharma companies